tiprankstipranks
Trending News
More News >
OncoArendi Therapeutics SA (PL:MOC)
:MOC
Poland Market
Advertisement

OncoArendi Therapeutics SA (MOC) Technical Analysis

Compare
Followers

Summary of all the Indicators

Overall Consensus
Neutral
9Bullish
3Neutral
10Bearish
Technical Analysis Consensus
Buy
5Bullish
3Neutral
2Bearish
Moving Average Consensus
Sell
4Bullish
0Neutral
8Bearish
OncoArendi Therapeutics SA’s (MOC) Moving Averages Convergence Divergence (MACD) indicator is 0.03, suggesting OncoArendi Therapeutics SA is a Sell.
OncoArendi Therapeutics SA’s (MOC) 20-Day exponential moving average is 7.35, making it a Buy.
OncoArendi Therapeutics SA’s (MOC) 50-Day exponential moving average is 7.30, making it a Buy.

OncoArendi Therapeutics SA (MOC) Pivot Points

Oct 01, 2025, 08:28 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
7.19
7.26
7.34
7.41
7.49
7.56
7.64
Fibonacci
7.26
7.31
7.35
7.41
7.46
7.50
7.56
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

OncoArendi Therapeutics SA (MOC) Moving Averages

Oct 01, 2025, 08:28 AM
Period
Simple
Exponential
MA5
7.43Sell
7.42Sell
MA10
7.45Sell
7.39Sell
MA20
7.15Buy
7.35Buy
MA50
7.59Sell
7.30Buy
MA100
7.02Buy
7.41Sell
MA200
7.98Sell
8.19Sell
OncoArendi Therapeutics SA’s (MOC) 10-Day exponential moving average is 7.39, making it a Sell.
OncoArendi Therapeutics SA’s (MOC) 100-Day exponential moving average is 7.41, making it a Sell.
OncoArendi Therapeutics SA’s (MOC) 50-day simple moving average is 7.59, creating a Sell signal.
OncoArendi Therapeutics SA’s (MOC) 100-day simple moving average is 7.02, creating a Buy signal.
OncoArendi Therapeutics SA’s (MOC) 200-day simple moving average is 7.98, creating a Sell signal.

OncoArendi Therapeutics SA (MOC) Technical Indicators

Oct 01, 2025, 08:28 AM
Name
Value
Implied Action
RSI (14)
50.88
Neutral
STOCH (9,6)
61.27
Neutral
STOCHRSI (14)
81.70
Sell
MACD (12,26)
0.03
Sell
ADX (14)
16.71
Buy
Williams %R
-22.46
Buy
CCI (14)
45.35
Neutral
ATR (14)
0.33
-
Ultimate Oscillator
73.01
Buy
ROC
15.70
Buy
OncoArendi Therapeutics SA’s (MOC) Relative Strength Index (RSI) is 50.88, creating a Neutral signal.
OncoArendi Therapeutics SA’s (MOC) Trend Strength Indicator (ADX) is 16.71, creating a Buy signal.
OncoArendi Therapeutics SA’s (MOC) Commodity Channel Index (CCI) is 45.35, creating a Neutral signal.
OncoArendi Therapeutics SA’s (MOC) Price Rate of Change (ROC) is 15.70, creating a Buy signal.

FAQ

Is MOC a Buy, Hold, or Sell?
Based on MOC’s technical indicators, MOC is a Hold.
    What is MOC’s RSI (14)?
    MOC’s RSI (14) is 50.88, which suggests MOC is a Neutral.
      What is MOC’s MACD?
      MOC’s MACD is 0.03, which suggests MOC is a Sell.
        What is MOC’s 5-day moving average?
        MOC’s 5-day moving average is 7.43, which suggests MOC is a Sell.
          What is MOC’s 20-day moving average?
          MOC 20-day moving average is 7.15, which suggests MOC is a Buy.
            What is MOC’s 50-day moving average?
            MOC’s 50-day moving average is 7.59, which suggests MOC is a Sell.
              What is MOC’s 200-day moving average?
              MOC’s 200-day moving average is 7.98, which suggests MOC is a Sell.
                What is MOC’s Williams % R (14)?
                MOC’s Williams % R (14) is -22.46, which suggests MOC is a Buy.
                  What is MOC’s CCI (14)?
                  MOC’s CCI (14) is 45.35, which suggests MOC is a Neutral.
                    What is the share price of OncoArendi Therapeutics SA?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis